Sex differences in pharmacokinetics of antidepressants. - Wikidata - wikimedia - TriplyDB

Sex differences in pharmacokinetics of antidepressants.

Sex differences in pharmacokinetics of antidepressants.

http://www.wikidata.org/entity/Q37824711

about

Sex differences in animal models of psychiatric disorders.Individual differences and the characterization of animal models of psychopathology: a strong challenge and a good opportunity.Bupropion for the treatment of seasonal affective disorder.Sex-Specific and Estrous Cycle-Dependent Antidepressant-Like Effects and Hippocampal Akt Signaling of Leptin.Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormones Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51.Pharmacogenetic considerations for late life depression therapy.Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.The ups and downs of modelling mood disorders in rodents.Preclinical sex differences in depression and antidepressant response: Implications for clinical research.Sex, hormones, and genotype interact to influence psychiatric disease, treatment, and behavioral research.Modelling depression in animals: at the interface of reward and stress pathways.[Gender differences in acute and chronic pain conditions. Implications for diagnosis and therapy].Gender in Endocrine Diseases: Role of Sex Gonadal Hormones

P2860

Q30401732-A8771C90-74C5-4291-B7DF-0938B3E6D684 Q30446936-94D1DCC2-67E6-4876-8DC4-7E8F3186B196 Q34346558-6D7B29AF-3AC5-42B8-A451-1471335A6280 Q36107470-760E7E73-232F-416B-B12E-2CAE3C0A1EE6 Q36775163-D60C71EB-15CF-4ABC-A1C6-8C382CAAF7D4 Q38006721-EB8384BB-B895-4F95-96C3-5AB8CC54E41E Q38103882-DBB7AE2A-6106-49C3-BD19-487856E4CF47 Q38214488-5651B1D5-96FD-493B-9F9B-D7A3EC0F9C1B Q38250047-B298CB46-1DF6-4971-A74B-DAC00ACF2051 Q38792679-30356E88-8C00-4EDD-9814-036C04C83FFC Q39015400-9D7D7A40-FB6D-4B59-B8BD-1696515E78EE Q39146103-844F5118-8F2E-49C8-AD37-318C2C0B0F5B Q44391988-531DB640-0103-4FBC-81CF-435E02576C97 Q58695108-E3128AFF-D80D-40CA-BEB8-D4F572D3B3D4

P2860

Sex differences in pharmacokinetics of antidepressants.

http://www.wikidata.org/entity/Q37824711

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sex differences in pharmacokinetics of antidepressants.

@en

Sex differences in pharmacokinetics of antidepressants.

@nl

type

label

Sex differences in pharmacokinetics of antidepressants.

@en

Sex differences in pharmacokinetics of antidepressants.

@nl

prefLabel

Sex differences in pharmacokinetics of antidepressants.

@en

Sex differences in pharmacokinetics of antidepressants.

@nl

P1433

Q37824711-0AC75CCC-9009-4475-83EF-BE64B2D03C12

P1476

Q37824711-F052D0F9-566D-4E0E-8634-24C68F4E2E9F

P2093

Q37824711-26870B63-B8CB-4978-B543-67139753EC98

P2860

Q37824711-07102469-0D42-4CDF-B5E6-27B48B8184D4

Q37824711-072DE579-7A93-4240-83A0-5B1B95BFB38A

Q37824711-07FCE6CC-02A1-48AA-B21F-D6F436E8718E

Q37824711-081E3A5D-A7C2-4B89-A808-AF1BC03574D7

Q37824711-0A458822-7B64-4F96-B147-FC3EDA3E7E55

Q37824711-0B101AD3-A42E-4801-BFF3-46BEFD441B48

Q37824711-0CD352EF-7B23-4324-9D81-170FE4E7CDA0

Q37824711-12547A2F-8AFB-46D1-8E61-D43CDF60F0A6

Q37824711-15166C86-2EDC-4354-860D-95F0D001D388

Q37824711-17781CC5-3B1A-4246-A70C-F4841C2BD287

P304

Q37824711-73454A95-07E0-4F68-B4C6-632704ADAB76

P31

Q37824711-367d86b5-8361-43bc-82ae-c79879cd0df5

Q37824711-FC79CB73-DAC0-4994-B54C-4CA1B6819199

P356

Q37824711-BF48D8FA-DAAE-44E4-9C5E-C2B5D26B07AD

P407

Q37824711-ACEF745D-0884-435A-8A56-76F080C28ECD

P433

Q37824711-86C2F8E4-17D5-4582-B18E-50AEC1A6415B

P478

Q37824711-368B322E-EB36-4CC8-B31D-F4711AC7B6DF

P50

Q37824711-14D851F3-BEC8-499D-9D06-14CE69BD6896

Q37824711-44321D25-F3F4-4A6C-AA54-CA5F61D64F6A

P577

Q37824711-EF739C0C-9814-4EC3-9DF6-A548B96EDAF5

P5875

Q37824711-D11111EB-A4A1-4DDD-82F4-B6A4B44BA4F6

P698

Q37824711-9072F7FF-E7B5-4373-B27B-340CE5E42E9A

P356

17425255.2011.544250

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Sex differences in pharmacokinetics of antidepressants.

@en

P2093

Zeta Papadopoulou-Daifoti

http://www.w3.org/2001/XMLSchema#string

P2860

UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.

Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetine.

Gender differences in drug responses.

Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice.

Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder.

Sex heterogeneity in pharmacogenetic smoking cessation clinical trials

Gender differences in depression and antidepressant pharmacokinetics and adverse events.

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

P304

213-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2011.544250

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Nikolaos Kokras

Christina Dalla

P577

2010-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49715972

http://www.w3.org/2001/XMLSchema#string

P698

21192772

http://www.w3.org/2001/XMLSchema#string